Qualified companies are merging with Nasdaq and NYSE SPACs as an alternative to traditional public offerings. Many OTC companies are frustrated by the lack of market makers in the OTC market and resulting low trading volume and valuations. OTC companies can leverage SPAC mergers as an alternative to uplisting.
Benefits
- Raise Large Amounts of Capital: SPACs typically have between $50M and $300M of capital in trust.
- More Liquidity: NASDAQ and NYSE are far more liquid markets, which typically leads to higher valuations
- Greater Institutional Investor Access: Many institutional investors will not invest in OTC-listed companies
There are hundreds of SPACs seeking qualified targets to acquire.
SPACs look for companies that are:
Reasonably Valued
PCAOB Audited
Public-Ready With Qualified Management Team